
U.S. stocks were lower, with the Nasdaq Composite falling around 0.1% on Tuesday.
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) rose sharply during Tuesday's session after the company announced it entered into an agreement to be acquired by Novartis.

U.S. stocks were lower, with the Nasdaq Composite falling around 0.1% on Tuesday.
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) rose sharply during Tuesday's session after the company announced it entered into an agreement to be acquired by Novartis.